The short version.
If you read nothing else, read this. The whole guide in a handful of bullets.
- What it is: Retatrutide (Lilly's LY3437943) is an investigational triple agonist that activates the GLP-1, GIP, and glucagon receptors at once. It is the lab-made version of a compound still in trials.
- What people run it for: weight loss, where phase 2 results reached roughly 24% of body weight at 48 weeks, the highest seen so far in obesity trials.
- Typical dose: start at 2 mg once weekly, titrate up every 4 weeks toward a target of 8 to 12 mg weekly.
- Routes: once-weekly subcutaneous injection is the only practical route. It is not an oral peptide.
- Cycle: slow titration over the first 12 or more weeks, then a steady maintenance dose, run under guidance rather than indefinitely on your own.
- Honest caveat: the human evidence is unusually strong for a research peptide, but Retatrutide is still investigational and not approved anywhere. It is sold for research use only, and this is not medical advice.
Quick reference.
| Typical dose | 2 mg start, titrated toward 8 to 12 mg weekly |
|---|---|
| Routes | Subcutaneous injection, once weekly |
| Frequency | Once a week, same day each week |
| Cycle length | Slow titration over ~12+ weeks, then maintenance |
| Best for | Significant weight loss and metabolic improvement |
What is Retatrutide?
Retatrutide is a peptide, which simply means a chain of amino acids, the same building blocks that make up the proteins in your body. It is a 39-amino-acid molecule developed by Eli Lilly under the code name LY3437943, designed to act on three different hormone receptors at the same time.
Those three receptors are GLP-1 and GIP, which most people know from drugs like semaglutide and tirzepatide, plus a third one, glucagon. Hitting all three together is the whole point: the first two calm appetite and steady blood sugar, while the glucagon arm nudges the body to burn more energy. That combination is why it is sometimes called a GLP-3.
The version sold by vendors arrives as a freeze-dried white powder in a small sealed vial. It is not a steroid, not a stimulant, and not a hormone you are replacing. People watch it for one thing above all: weight loss numbers that, in published trials, run higher than anything that came before it.
Worth saying plainly: Retatrutide is not an approved medicine anywhere. It is sold strictly for research use only, and while the trial data is genuinely strong, what a vendor ships is not the studied pharmaceutical product and has not been through any approval. We get into what that means further down.
How it works in the body.
You do not need a biology degree to follow this. Here is the simple picture, then a little more for the curious.
The core idea is that Retatrutide pulls three metabolic levers at once. Two of them turn hunger down, and the third turns energy burn up. Most weight loss drugs pull one or two of these; Retatrutide is the first to pull all three together.
- GLP-1 activation. This is the familiar appetite lever. It boosts insulin after meals, slows how fast your stomach empties, and signals fullness to the brain, so you eat less without white-knuckling it.
- GIP activation. A second incretin pathway that works alongside GLP-1 on insulin and appetite, and appears to improve how the body handles fat and sugar. It is the same second arm that tirzepatide uses.
- Glucagon activation. The piece that makes Retatrutide different. Glucagon agonism raises energy expenditure and pushes fat burning, especially in the liver, adding an output effect on top of the reduced intake.
How to take it: routes of administration.
Retatrutide is an injectable peptide, full stop. Like semaglutide and tirzepatide, it is not a meaningful oral option, so the only real route is a once-weekly subcutaneous shot. Here is the honest comparison.
| Route | Typical dose | Absorption | Best for | Difficulty |
|---|---|---|---|---|
| Subcutaneous | 2 to 12 mg | Reliable, systemic | Weekly weight loss dosing | Tiny needle, easy to learn |
| Intramuscular | Not standard | High | Not used for this | Unnecessary and harsher |
| Oral | Not practical | Very low | Not recommended | Destroyed by digestion |
Subcutaneous injection
The only route that matters here. A tiny insulin needle goes into the fat just under the skin, not into muscle, once a week. It is the same simple shot used for semaglutide and tirzepatide, and it is far less intimidating than it sounds.
Intramuscular
There is no reason to inject Retatrutide into muscle. The trials used subcutaneous dosing, the once-weekly profile is built around it, and an intramuscular shot would just be deeper and more uncomfortable for no benefit.
Oral
Like other GLP-1 peptides, Retatrutide does not survive digestion, so there is no practical oral version. If you want a pill instead of a needle, that is a different compound, orforglipron, not this one.
Where to inject.
If you go this route, these are the sites people use. Rotate so no single area gets sore.
The easiest spots are the belly (about 2 inches either side of the navel), the love handles, the front of the thigh, and the back of the upper arms. Rotate every injection.
So which should a beginner pick? There is really only one answer: subcutaneous, once a week. The needle is tiny, absorption is reliable, and it matches exactly how the compound was studied. Intramuscular and oral are not options worth considering for Retatrutide.
Reconstitution: mixing it.
Retatrutide arrives as a dry powder, so before you can inject it you reconstitute it, which just means adding liquid to turn the powder into something you can draw into a syringe. It sounds technical but takes about a minute.
Once it is mixed, the only real question is how many units to draw. That depends on your vial size, your water amount, and your target dose, and it is easy to get wrong by hand, which matters more here because doses are small and potent.
- Use bacteriostatic water, often called BAC water. The small amount of preservative keeps the mixed vial usable for weeks.
- Add the water slowly, down the inside wall of the vial. A common mix is a 10 mg vial plus 1 mL of BAC water, which gives a concentration of 10 mg/mL.
- Swirl, do not shake. Gently roll the vial until the powder dissolves. Shaking can damage the peptide.
- Store it in the fridge once mixed, and keep it out of direct light.
Open the dosage calculator to turn your vial and dose into an exact number of units. As a worked example: a 10 mg vial mixed with 1 mL of BAC water gives 10 mg/mL, so a 2 mg dose is 0.2 mL, which is 20 units on a U-100 insulin syringe, and that vial holds about 5 doses at the starting dose.
Dosing by goal.
There is no single official dose for Retatrutide, because it is not an approved medicine. What follows is the titration pattern used in the published trials. The defining feature of Retatrutide dosing is the slow ramp: you start low and step up every four weeks to keep nausea in check.
Starting dose
Trials began at 2 mg once weekly for the first few weeks. The point of the low start is not to lose weight quickly but to let the gut adjust before the dose climbs.
Titration
Every 4 weeks the dose was stepped up, moving through 4 mg and 8 mg over roughly 12 weeks. Each step is where nausea tends to flare, so people hold a step longer if they are struggling rather than rushing the next jump.
Target dose
The studied target doses were 8 mg and 12 mg once weekly, with 12 mg producing the largest weight loss, around 24% at 48 weeks, and also the most side effects. Many people settle at 8 mg as a balance of results and tolerability.
The introductory dose. Low on purpose to let your gut adjust before stepping up. Weight loss is modest here.
Step up every four weeks. This is where nausea flares, so hold a step longer if you need to rather than rushing.
The maintenance range. 12 mg gives the biggest results and the most side effects; 8 mg is a common balance point.
Cycling and timing.
Retatrutide is not really cycled the way a recovery peptide is. It is a weight loss compound, so the pattern that mirrors the trials is a long, steady run: titrate up over the first months, then hold a maintenance dose for as long as the weight loss goal is active.
The honest catch is what happens when you stop. Like other GLP-1 drugs, appetite tends to return when the compound is discontinued, and some weight regain is common without lasting diet and activity changes. This is a long-game tool, not a short blast.
- Ramp slowly through the titration steps rather than jumping to a high dose, which only worsens nausea.
- Hold a maintenance dose once you reach a level that balances results and side effects, often 8 mg.
- Plan for the off-ramp. Appetite and some weight tend to come back after stopping, so a tapering plan and lifestyle changes matter. This is a conversation for a licensed provider.
Stacking Retatrutide.
Retatrutide is potent on its own, and the trial evidence is all single-agent, so stacking is not the norm. When people do combine it, the aim is usually to manage side effects or add satiety, not to pile on more agonists.
Standard approach
The most evidence-aligned way to run it. Every published trial used Retatrutide as a single agent with slow titration, so running it alone is what the data actually supports. For most people this is the right call.
View stack →Added satiety
Some researchers add the amylin analog cagrilintide to push satiety further. This is experimental layering with no trial behind the specific combination, and it stacks the side-effect load. Treat it as unproven.
View stack →See full recipes, dosing, and how people run them on the stacks page.
Side effects and safety.
In trials and the reports we see, Retatrutide's side effects are mostly gastrointestinal and cluster around dose increases. They tend to ease as the body adjusts. The ones people mention most often are:
- Nausea, the most common by far, reported by a majority of people at the 12 mg dose, worst right after each step up.
- Vomiting and diarrhea, common during titration and usually improving as the dose holds steady.
- Constipation, reported by a meaningful share of users.
- Dysesthesia, odd skin sensations like tingling, noted in about one in five people at the 12 mg dose, a finding fairly specific to Retatrutide.
Who should be cautious.
Some people have clear reasons to be extra careful, or to avoid Retatrutide entirely until they have spoken with a licensed provider.
- Pregnant or breastfeeding. There is no safety data here, so this is a hard avoid.
- A personal or family history of medullary thyroid cancer or MEN2. This is a standard contraindication for the GLP-1 drug class and a clear reason to avoid. Talk to a doctor, not a forum.
- History of pancreatitis or serious gut disease. The GI effects are strong, so this warrants real caution.
- Competing athletes. Retatrutide is banned by WADA and will show up as a prohibited substance.
- Anyone on other medications or managing diabetes. Because it lowers blood sugar and slows digestion, it can interact with other drugs. Talk to your provider first.
And the universal one: whoever you are, talk to a licensed healthcare provider before starting Retatrutide. This guide is educational, not a substitute for personalized medical advice.
Where to buy it safely.
This is where a lot of beginners get burned, because peptide quality varies wildly between vendors and the cheapest vial is not always the real deal. With a high-demand compound like Retatrutide the risk is worse. Our honest take: do not shop on price alone, shop on price plus independent lab data.
- Compare vendors side by side. Price ranges are wide, and the difference between the lowest and highest listing can be large for the exact same compound.
- Look for recent third-party lab tests. The gold standard the community looks for is a recent Janoshik certificate of analysis showing purity for the batch you are actually buying.
- Favor recent COAs. An old lab result on a different batch tells you little. The fresher the test, the more it means.
- Be skeptical of suspiciously cheap listings with no testing behind them, and of anything marketed as a finished medicine.
That is exactly the comparison we put together. On our Retatrutide product page you can compare vendor prices, see which batches have public lab data, and view the grades we assign from that data. From there you can head to the buy page to line up your options.
Questions, answered straight.
Is Retatrutide legal?
Retatrutide is not an approved drug and is not sold for human use. The vendors we compare offer it strictly for research use only, and the FDA has warned compounders against selling it. It is also on WADA's prohibited list, so competing athletes should steer clear. Rules vary by country, so check what applies where you are.
How is it different from tirzepatide and semaglutide?
Semaglutide hits one receptor (GLP-1) and tirzepatide hits two (GLP-1 and GIP). Retatrutide hits three, adding glucagon, which raises energy expenditure on top of appetite suppression. In trials that third arm is linked to larger weight loss, but also more nausea and other side effects.
How much weight did it produce in trials?
In the phase 2 obesity trial, the 12 mg dose produced about 24% mean body weight loss at 48 weeks, with 8 mg close behind. Reported phase 3 results have been even higher over a longer period. These are trial figures for the genuine pharmaceutical, not a promise for grey-market product.
Why does it cause so much nausea?
Nausea comes mostly from the GLP-1 and glucagon activity slowing digestion and acting on appetite centers. It is worst right after each dose increase, which is exactly why the protocol titrates up slowly over months rather than starting high.
Does it need refrigeration?
Keep the sealed, freeze-dried vial in the fridge and out of light. Once you mix it with bacteriostatic water, store it refrigerated and use it within a few weeks. Do not freeze a reconstituted vial.
How do I figure out the dose in units?
Use our calculator. Enter your vial size, how much bacteriostatic water you added, and your target dose, and it tells you exactly how many units to draw on a U-100 syringe. The dosage calculator handles the math for you.